Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
35M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
328K
-
Shares change
-
-15K
-
Total reported value, excl. options
-
$860K
-
Value change
-
-$48K
-
Number of sells
-
-1
-
Price
-
$2.62
Significant Holders of Apyx Medical Corp - Common Stock (APYX) as of Q4 2023
2 filings reported holding APYX - Apyx Medical Corp - Common Stock as of Q4 2023.
Apyx Medical Corp - Common Stock (APYX) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 328K shares
of 35M outstanding shares and own 0.94% of the company stock.
Largest 10 shareholders include Archon Capital Management LLC (3.45M shares), ROYCE & ASSOCIATES LP (2.16M shares), AIGH Capital Management LLC (2.04M shares), VANGUARD GROUP INC (1.48M shares), RTW INVESTMENTS, LP (1.03M shares), Taylor Frigon Capital Management LLC (639K shares), HORIZON KINETICS ASSET MANAGEMENT LLC (615K shares), Silverberg Bernstein Capital Management LLC (614K shares), Raymond James Financial Services Advisors, Inc. (609K shares), and Worth Venture Partners, LLC (518K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.